Navigation Links
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
Date:8/21/2008

charges ($5.4 million, or $0.44 per share tax-effected), related to

the sale of the Company's endovascular business during the fourth

quarter of fiscal year 2008.

Note: To supplement our consolidated financial statements presented in

accordance with GAAP, Kensey Nash Corporation uses non-GAAP measures

of adjusted earnings per share, which are adjusted from our GAAP

results to exclude certain expenses. These non-GAAP adjustments are

provided to enhance the user's overall understanding of our

historical and current financial performance and our prospects for

the future. We believe the non-GAAP results provide useful

information to both management and investors by excluding certain

expenses that we believe are not indicative of our core operating

results.

These non-GAAP measures will provide investors and management with

an alternative method for assessing Kensey Nash's operating results

in a manner consistent with future presentation. Further, these

non-GAAP results are one of the primary indicators management uses

for planning and forecasting in future periods. The presentation of

this additional information should not be considered in isolation or

as a substitute for results prepared in accordance with accounting

principles generally accepted in the United States.

Supplemental Non-GAAP Financial Measures and Reconciliations

Kensey Nash Corporation

Non-GAAP Financial Measures and Reconciliations

Adjusted Income and Earnings Per Share Reconciliation

(Unaudited) (Unaudited)

As Reported Non-GAAP Adjustments As Adjusted

Three Emboli
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
3. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
4. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
6. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
7. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
10. Arpida Reports Interim Results for Six Months to 30 June 2008
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... today announced that it will release fourth quarter and ... March 10, 2015 after the close of the U.S. ... and webcast on Tuesday, March 10, 2015 at 4:30 ... results and recent corporate developments. For both ...
(Date:3/2/2015)... Massachusetts (PRWEB) March 02, 2015 Outside ... services, today announced the addition of Debbie Casey as ... capabilities in the healthcare space. , Debbie ... most of which with Fresenius Medical Care North America ... leverage her extensive experience to work with Outside GC’s ...
(Date:2/27/2015)... GERMANTOWN, Md. and SUMMERLAND, British ... Corporation (NYSE: XON ), a leader ... an agreement to acquire  Okanagan Specialty Fruits (OSF), ... apple , the world,s first non-browning apple. Through ... trees yielding fruit that is more appetizing and convenient ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
... This release is available in Spanish . ... leading in Spain the European project within the VII Framework ... buildings which host large numbers of people, such as sports ... by the management and optimisation of energy in its three ...
... 5, 2011 Sangamo BioSciences, Inc. (Nasdaq: SGMO ... will provide an update on the progress of Sangamo,s ZFP ... strategy at 12:30 pm PT (3:30 pm ET) on Thursday, ... Conference which will be held in San Francisco. ...
... HOUSTON, Jan. 5, 2011 International energy pricing agency ... expansion into US and Canadian wood chip pricing complements ... broader European biomass indexation. " Argus understands ... to be at the forefront, providing transparency to emerging biomass ...
Cached Biology Technology:Tecnalia leads the integration of energy efficiency in sports facilities 2Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference 2Argus Launches North American Wood Chip Price Assessments 2
(Date:2/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD ... a new groundbreaking payment method. Payment accounts may be ... only be accessed if both the speech (the word ...
(Date:2/18/2015)... 2015  Cepheid (NASDAQ: CPHD ) today announced ... and invited investors to participate via webcast. , Cowen ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern Time ... FL Wednesday, March 4, 2015 at 10.25 a.m. ... live webcasts for these events, please visit Cepheid,s website at ...
(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... intimately familiar with the awe-inspiring photos of space shuttle launches ... But how many people have paused for even a second ... a two-week space shuttle mission or are living for months ... book The Astronaut,s Cookbook Tales, Recipes, and More ...
... 13 BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... identification solutions, today reported results for the third quarter ... The Company,s results reflected operating profitability for each quarter ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) , As a result of ...
... DALLAS Nov. 12, 2009 UT Southwestern ... to date for basic and patient-oriented research from the ... billion stimulus package President Barack Obama signed into law ... the National Science Foundation (NSF) and the National Institutes ...
Cached Biology News:The astronaut's cookbook 2BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 2BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 3BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 4BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 5BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 6UT Southwestern receives $42 million in Recovery Act stimulus funding 2UT Southwestern receives $42 million in Recovery Act stimulus funding 3
...
... Purity is >95%\nNEN Radiolabeled Ligands\n\nReceptor-related research has ... of new radiolabeled ligands selected to keep ... wide range of products and services for ... 400 state-of-the-art radioligands. If you do not ...
... The Polymerase gene from Thermus ... expressed in E. coli, then highly ... It is used in the amplification ... PCR. The quality of the Taq ...
... iTaq DNA polymerase is an ... for both conventional and real-time ... supplied at a concentration of ... includes 5,000 units polymerase, 25 ...
Biology Products: